no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acid sphingomyelinase deficiency: Laboratory diagnosis, genetic and epidemiologic aspects of a 50-year French cohort
|
Froissart, Roseline |
|
|
145 |
1 |
p. |
article |
2 |
Argentine program of home infusions with enzyme replacement therapy for lysosomal diseases: Results in safety, quality of life and adherence
|
Drelichman, Guillermo |
|
|
145 |
1 |
p. |
article |
3 |
Challenges in Gaucher disease: Perspectives from an expert panel
|
Grabowski, Gregory A. |
|
|
145 |
1 |
p. |
article |
4 |
Clinical and biochemical footprints of inherited metabolic diseases: Ia. Movement disorders, updated
|
Peacock, Dakota J.S.J. |
|
|
145 |
1 |
p. |
article |
5 |
Corrigendum to “Genetic Analysis and multimodal imaging confirm m.12148 T>C mitochondrial variant pathogenicity leading to multisystem dysfunction” [Molecular Genetics and Metabolism 144 (2025); 109049]
|
Belle, Kinsley |
|
|
145 |
1 |
p. |
article |
6 |
Corrigendum to “Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients” [Molecular Genetics and Metabolism 2025 Mar;144(3):109025].
|
Kolstad, Josephine |
|
|
145 |
1 |
p. |
article |
7 |
Corrigendum to “The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial” [Molecular Genetics and Metabolism Volume 143, Issue 4, December 2024, 108607]
|
Pinto, Alex |
|
|
145 |
1 |
p. |
article |
8 |
Cover 2 / Ed. Board
|
|
|
|
145 |
1 |
p. |
article |
9 |
Early postnatal hepatocyte transplantation in a child with molybdenum cofactor deficiency type B
|
Selvanathan, A. |
|
|
145 |
1 |
p. |
article |
10 |
Efficacy and safety of Nitisinone for patients with alkaptonuria: A systematic review with metanalysis
|
Mayrink, Flávia Diniz |
|
|
145 |
1 |
p. |
article |
11 |
Enhancing Fabry disease screening and diagnostic efficiency: Integration of enzyme, biomarker, and next-generation sequencing testing
|
Pan, Yinghong |
|
|
145 |
1 |
p. |
article |
12 |
Extracellular chaperones in lysosomal storage diseases
|
İnci, Aslı |
|
|
145 |
1 |
p. |
article |
13 |
Goal attainment in PMM2-CDG: A new approach measuring meaningful clinical outcomes
|
Verberkmoes, Sanne |
|
|
145 |
1 |
p. |
article |
14 |
Inter-individuality in the transport and effect of phenylalanine in the brain: A double case report of two ‘unusual’ phenylketonuria patients
|
van Steenis, E.M. |
|
|
145 |
1 |
p. |
article |
15 |
Letter to the editor: SSR4-CDG, an ultra-rare X-linked congenital disorder of glycosylation affecting the TRAP complex: Review of 22 affected individuals including the first adult patient
|
Trujillo, Ileana |
|
|
145 |
1 |
p. |
article |
16 |
Mechanistic insights into arimoclomol mediated effects on lysosomal function in Niemann-pick type C disease
|
Shammas, Hadeel |
|
|
145 |
1 |
p. |
article |
17 |
Newborn screening follow-up for very long-chain acyl-CoA dehydrogenase deficiency in Colorado: Working towards a standardized protocol
|
Crenshaw, M.M. |
|
|
145 |
1 |
p. |
article |
18 |
Recruitment through empathy and education: The role of the clinical experience on workforce development
|
Achanta, Rishisree |
|
|
145 |
1 |
p. |
article |
19 |
RNA sequencing driven diagnosis expands the phenotypic spectrum of NBAS deficiency
|
Silverstein, Sarah |
|
|
145 |
1 |
p. |
article |
20 |
Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extension
|
Ramaswami, Uma |
|
|
145 |
1 |
p. |
article |
21 |
The clinical value of peripheral biogenic amine metabolites in early-treated phenylketonuria
|
Manti, Filippo |
|
|
145 |
1 |
p. |
article |
22 |
The role of large language models in medical genetics
|
Merdler-Rabinowicz, Rona |
|
|
145 |
1 |
p. |
article |
23 |
Using multiple modalities to confirm diagnosis in patients with suspected peroxisome biogenesis disorders
|
Cheung, Anthony C.T. |
|
|
145 |
1 |
p. |
article |